Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China flag China · Delayed Price · Currency is CNY
24.27
+0.86 (3.67%)
At close: Mar 6, 2026

SHA:688163 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
196.21194.92190.13174.21207.5
Other Revenue
--0.020.011.19
196.21194.92190.14174.22208.69
Revenue Growth (YoY)
0.66%2.51%9.14%-16.52%12.46%
Cost of Revenue
-45.849.8433.536.33
Gross Profit
196.21149.11140.3140.72172.36
Selling, General & Admin
-76.7174.3573.7162.81
Research & Development
-23.8430.4115.4625.76
Other Operating Expenses
134.171.681.531.211.45
Operating Expenses
134.17102.96107.0890.2890.34
Operating Income
62.0446.1533.2250.4582.03
Interest Expense
--0.43-0.65-0.68-0.71
Interest & Investment Income
-6.1210.6216.31.48
Currency Exchange Gain (Loss)
--0.030.120.49-0.12
Other Non Operating Income (Expenses)
-0.30.23-0.250.42-0.3
EBT Excluding Unusual Items
61.7452.0443.0666.9782.38
Gain (Loss) on Sale of Investments
--4.972.592.62-0.79
Gain (Loss) on Sale of Assets
-0.41-0.01-0.07-0.25
Other Unusual Items
-3.09-0.234.536.54
Pretax Income
61.7450.5745.4274.0487.88
Income Tax Expense
10.036.286.649.8411.39
Earnings From Continuing Operations
51.7144.2938.7764.276.48
Net Income
51.7144.2938.7764.276.48
Net Income to Common
51.7144.2938.7764.276.48
Net Income Growth
16.76%14.23%-39.60%-16.06%21.07%
Shares Outstanding (Basic)
10810810810281
Shares Outstanding (Diluted)
10810810810281
Shares Change (YoY)
-0.27%0.30%5.70%25.24%0.46%
EPS (Basic)
0.480.410.360.630.94
EPS (Diluted)
0.480.410.360.630.94
EPS Growth
17.07%13.89%-42.86%-32.98%20.51%
Free Cash Flow
--9.124.1541.4664.68
Free Cash Flow Per Share
--0.080.040.410.80
Dividend Per Share
-0.3200.2000.7500.900
Dividend Growth
-60.00%-73.33%-16.67%-
Gross Margin
100.00%76.50%73.79%80.77%82.59%
Operating Margin
31.62%23.68%17.47%28.96%39.30%
Profit Margin
26.36%22.72%20.39%36.85%36.65%
Free Cash Flow Margin
--4.68%2.18%23.79%30.99%
EBITDA
81.465.549.4664.4396.15
EBITDA Margin
41.48%33.61%26.01%36.98%46.07%
D&A For EBITDA
19.3619.3616.2413.9814.12
EBIT
62.0446.1533.2250.4582.03
EBIT Margin
31.62%23.68%17.47%28.96%39.30%
Effective Tax Rate
16.24%12.41%14.62%13.29%12.97%
Revenue as Reported
-194.92190.14174.22208.69
Source: S&P Global Market Intelligence. Standard template. Financial Sources.